Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion
- PMID: 18787099
- PMCID: PMC2543079
- DOI: 10.2353/ajpath.2008.080252
Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion
Abstract
Chronic intestinal pseudo-obstruction is a life-threatening condition of unknown pathogenic mechanisms. Chronic intestinal pseudo-obstruction can be a feature of mitochondrial disorders, such as mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), a rare autosomal-recessive syndrome, resulting from mutations in the thymidine phosphorylase gene. MNGIE patients show elevated circulating levels of thymidine and deoxyuridine, and accumulate somatic mitochondrial DNA (mtDNA) defects. The present study aimed to clarify the molecular basis of chronic intestinal pseudo-obstruction in MNGIE. Using laser capture microdissection, we correlated the histopathological features with mtDNA defects in different tissues from the gastrointestinal wall of five MNGIE and ten control patients. We found mtDNA depletion, mitochondrial proliferation, and smooth cell atrophy in the external layer of the muscularis propria, in the stomach and in the small intestine of MNGIE patients. In controls, the lowest amounts of mtDNA were present at the same sites, as compared with other layers of the gastrointestinal wall. We also observed mitochondrial proliferation and mtDNA depletion in small vessel endothelial and smooth muscle cells. Thus, visceral mitochondrial myopathy likely causes gastrointestinal dysmotility in MNGIE patients. The low baseline abundance of mtDNA molecules may predispose smooth muscle cells of the muscularis propria external layer to the toxic effects of thymidine and deoxyuridine, and exposure to high circulating levels of nucleosides may account for the mtDNA depletion observed in the small vessel wall.
Figures




Similar articles
-
Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine.Gastroenterology. 2006 Mar;130(3):893-901. doi: 10.1053/j.gastro.2006.01.004. Gastroenterology. 2006. PMID: 16530527
-
Evaluation of gastrointestinal mtDNA depletion in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).Methods Mol Biol. 2011;755:223-32. doi: 10.1007/978-1-61779-163-5_18. Methods Mol Biol. 2011. PMID: 21761307
-
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes.Neurologist. 2004 Jan;10(1):8-17. doi: 10.1097/01.nrl.0000106919.06469.04. Neurologist. 2004. PMID: 14720311 Review.
-
Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations.Ann Neurol. 2000 Jun;47(6):792-800. Ann Neurol. 2000. PMID: 10852545
-
MNGIE: from nuclear DNA to mitochondrial DNA.Neuromuscul Disord. 2001 Jan;11(1):7-10. doi: 10.1016/s0960-8966(00)00159-0. Neuromuscul Disord. 2001. PMID: 11166160 Review.
Cited by
-
Alpers-Huttenlocher syndrome: the role of a multidisciplinary health care team.J Multidiscip Healthc. 2016 Jul 26;9:323-33. doi: 10.2147/JMDH.S84900. eCollection 2016. J Multidiscip Healthc. 2016. PMID: 27555780 Free PMC article. Review.
-
Mitochondrial neurogastrointestinal encephalomyopathy: Clinical and biochemical impact of allogeneic stem cell transplantation in a Greek patient with one novel TYMP mutation.Mol Genet Metab Rep. 2021 Dec 3;30:100829. doi: 10.1016/j.ymgmr.2021.100829. eCollection 2022 Mar. Mol Genet Metab Rep. 2021. PMID: 34926160 Free PMC article.
-
Evidence of enteric angiopathy and neuromuscular hypoxia in patients with mitochondrial neurogastrointestinal encephalomyopathy.Am J Physiol Gastrointest Liver Physiol. 2021 May 1;320(5):G768-G779. doi: 10.1152/ajpgi.00047.2021. Epub 2021 Mar 3. Am J Physiol Gastrointest Liver Physiol. 2021. PMID: 33655764 Free PMC article.
-
Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association.Acta Biomed. 2018 Dec 17;89(9-S):22-32. doi: 10.23750/abm.v89i9-S.7956. Acta Biomed. 2018. PMID: 30561392 Free PMC article. Review.
-
Novel understanding on genetic mechanisms of enteric neuropathies leading to severe gut dysmotility.Eur J Histochem. 2021 Nov 25;65(s1):3289. doi: 10.4081/ejh.2021.3289. Eur J Histochem. 2021. PMID: 34818877 Free PMC article. Review.
References
-
- Connor FL, Di Lorenzo C. Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology. 2006;30:S29–S36. - PubMed
-
- Stanghellini V, Cogliandro RF, De Giorgio R, Barbara G, Salvioli B, Corinaldesi R. Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil. 2007;19:440–452. - PubMed
-
- Jain D, Moussa K, Tandon M, Culpepper-Morgan J, Proctor DD. Role of interstitial cells of Cajal in motility disorders of the bowel. Am J Gastroenterol. 2003;98:618–624. - PubMed
-
- Bindoff L. Mitochondrial gastroenterology. Di Mauro S, Hirano M, Schon EA, editors. Abington, UK: Informa Healthcare,; Mitochondrial Medicine. 2006:143–159.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources